Published in Eur J Neurosci on July 01, 2004
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol (2007) 6.20
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev (2008) 3.51
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci (2010) 2.37
Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol (2009) 2.35
Mitochondrial CB₁ receptors regulate neuronal energy metabolism. Nat Neurosci (2012) 2.15
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol (2007) 2.05
Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J (2006) 2.01
Endocannabinoid signaling and synaptic function. Neuron (2012) 1.90
JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol (2010) 1.79
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther (2009) 1.74
Activity-dependent regulation of synapses by retrograde messengers. Neuron (2009) 1.73
Chemical probes of endocannabinoid metabolism. Pharmacol Rev (2013) 1.68
Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci (2012) 1.60
The endocannabinoid system and pain. CNS Neurol Disord Drug Targets (2009) 1.59
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J (2005) 1.50
A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci (2011) 1.50
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology (2009) 1.47
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol (2009) 1.46
Endocannabinoid signaling in microglial cells. Neuropharmacology (2008) 1.36
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol (2006) 1.30
Endocannabinoid mechanisms of pain modulation. AAPS J (2006) 1.28
Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci (2013) 1.27
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov (2009) 1.22
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci (2014) 1.18
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry (2012) 1.14
The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol (2010) 1.11
More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology (2013) 1.10
A fatty gut feeling. Trends Endocrinol Metab (2013) 1.10
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release. J Physiol (2007) 1.09
2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab (2012) 1.09
COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation. Br J Pharmacol (2011) 1.09
Endocannabinoids in the retina: from marijuana to neuroprotection. Prog Retin Eye Res (2008) 1.08
Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology (2015) 1.08
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol (2013) 1.08
The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology (2008) 1.07
Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci (2010) 1.06
Endocannabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol (2011) 1.05
Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci (2015) 1.04
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Pharmacol Res (2010) 1.04
The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci (2008) 1.04
Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett (2007) 1.04
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model. Br J Pharmacol (2008) 1.01
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience (2010) 1.01
Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem Biol (2009) 1.01
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol (2014) 1.00
The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci (2015) 0.99
Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectr (2007) 0.99
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci (2012) 0.99
Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem (2011) 0.99
Architecture of cannabinoid signaling in mouse retina. J Comp Neurol (2010) 0.99
Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. Pain (2012) 0.99
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. Br J Pharmacol (2009) 0.98
The evolution and comparative neurobiology of endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci (2012) 0.98
Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. J Biol Chem (2009) 0.98
Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. Neuropsychopharmacology (2014) 0.97
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci (2012) 0.96
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology (2011) 0.94
Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc Natl Acad Sci U S A (2012) 0.93
Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. Neuropsychopharmacology (2013) 0.93
Conformationally constrained analogues of 2-arachidonoylglycerol. Bioorg Med Chem Lett (2007) 0.92
Endocannabinoids in synaptic plasticity and neuroprotection. Neuroscientist (2014) 0.92
Time-dependent expression and distribution of monoacylglycerol lipase during the skin-incised wound healing in mice. Int J Legal Med (2011) 0.92
Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur Child Adolesc Psychiatry (2014) 0.92
Monoacylglycerol lipase - a target for drug development? Br J Pharmacol (2012) 0.91
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. J Neurosci (2015) 0.91
Advances in the discovery of N-acylethanolamine acid amidase inhibitors. Pharmacol Res (2014) 0.91
Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. Br J Pharmacol (2007) 0.90
Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Curr Neuropharmacol (2007) 0.90
Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain Behav (2012) 0.90
Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1. PLoS One (2011) 0.89
Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala. Alcohol Clin Exp Res (2011) 0.88
Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics (2012) 0.87
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. Eur J Pharmacol (2014) 0.87
Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag Res (2013) 0.86
A neuroplasticity hypothesis of chronic stress in the basolateral amygdala. Yale J Biol Med (2013) 0.86
Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent. Pharmacogenomics (2009) 0.86
Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells. J Physiol (2012) 0.85
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. Nat Commun (2015) 0.84
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. Neuropharmacology (2005) 0.84
Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons. Chem Biol (2015) 0.84
Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell. Front Psychiatry (2014) 0.83
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. Neuroscience (2011) 0.83
Monoglyceride lipase: Structure and inhibitors. Chem Phys Lipids (2015) 0.82
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins Other Lipid Mediat (2009) 0.81
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition. PLoS One (2013) 0.80
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context. Front Cell Neurosci (2015) 0.80
Assessment of a spectrophotometric assay for monoacylglycerol lipase activity. AAPS J (2010) 0.80
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. Eur J Neurosci (2014) 0.80
A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation. eNeuro (2016) 0.80
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. Psychopharmacology (Berl) (2015) 0.79
Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus. Front Neuroanat (2014) 0.79
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection. Mol Neurodegener (2015) 0.79
Endocannabinoids in the dentate gyrus. Prog Brain Res (2007) 0.79
Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([(11)C]MPPO) Based on α-Ketoheterocyclic Scaffold. ACS Chem Neurosci (2015) 0.78
α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors. Proc Natl Acad Sci U S A (2016) 0.78
Subcellular localization of NAPE-PLD and DAGL-α in the ventromedial nucleus of the hypothalamus by a preembedding immunogold method. Histochem Cell Biol (2013) 0.77
Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility. Int J Neuropsychopharmacol (2015) 0.77
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A (2001) 7.15
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70
Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci U S A (1999) 5.43
Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A (2002) 5.33
Differences between somatic and dendritic inhibition in the hippocampus. Neuron (1996) 4.85
A second endogenous cannabinoid that modulates long-term potentiation. Nature (1997) 4.79
Control of pain initiation by endogenous cannabinoids. Nature (1998) 4.73
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65
Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience (2001) 4.31
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci (1999) 3.45
Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (1997) 3.16
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A (2005) 2.96
An anorexic lipid mediator regulated by feeding. Nature (2001) 2.94
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther (2009) 2.55
Profiling serine hydrolase activities in complex proteomes. Biochemistry (2001) 2.46
Hippocampal pyramidal cells excite inhibitory neurons through a single release site. Nature (1993) 2.37
Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature (1987) 2.32
Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci (1999) 2.27
Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A (1997) 2.25
Selective vulnerability of the hippocampus in brain ischemia. Neuroscience (1991) 2.18
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci (2001) 2.15
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience (1984) 2.05
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience (2001) 2.05
Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J Neurosci (1997) 1.99
Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem (1995) 1.98
Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci (1996) 1.91
Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci U S A (2000) 1.89
Precision and variability in postsynaptic target selection of inhibitory cells in the hippocampal CA3 region. Eur J Neurosci (1993) 1.85
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature (1995) 1.83
Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum. J Physiol (1997) 1.82
Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem (2000) 1.81
Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry (1998) 1.80
Brain cannabinoids in chocolate. Nature (1996) 1.78
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry (2012) 1.77
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology (2002) 1.75
Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat. Eur J Neurosci (2001) 1.73
Synaptic input of horizontal interneurons in stratum oriens of the hippocampal CA1 subfield: structural basis of feed-back activation. Eur J Neurosci (1995) 1.72
Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. Mol Pharmacol (2007) 1.71
The endocannabinoid system in brain reward processes. Br J Pharmacol (2008) 1.71
Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex. Exp Brain Res (1986) 1.68
Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience (1996) 1.67
Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Biochemistry (1999) 1.67
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci U S A (2004) 1.66
Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci (1996) 1.62
Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem (2000) 1.61
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci (2004) 1.55
Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience (2003) 1.54
Selective GABAergic innervation of thalamic nuclei from zona incerta. Eur J Neurosci (2002) 1.53
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci (2002) 1.52
The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J Cell Biol (1997) 1.51
A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci (1998) 1.48
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol (2001) 1.45
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol (2001) 1.45
Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus. Neuroscience (1999) 1.45
Postsynaptic targets of GABAergic hippocampal neurons in the medial septum-diagonal band of broca complex. J Neurosci (1993) 1.44
Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci (2005) 1.43
Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience (1998) 1.43
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides. Vitam Horm (2001) 1.40
Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry (1999) 1.40
Elevated endogenous cannabinoids in schizophrenia. Neuroreport (1999) 1.38
Interneurons are the local targets of hippocampal inhibitory cells which project to the medial septum. Eur J Neurosci (2003) 1.37
Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature (2000) 1.36
The absence of a major Ca2+ signaling pathway in GABAergic neurons of the hippocampus. Proc Natl Acad Sci U S A (1998) 1.36
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport (2000) 1.36
CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience (2005) 1.35
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res (1997) 1.35
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol (2004) 1.34
The axo-axonic interneuron in the cerebral cortex of the rat, cat and monkey. Neuroscience (1982) 1.34
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther (2001) 1.33
Clarifying the catalytic roles of conserved residues in the amidase signature family. J Biol Chem (2000) 1.32
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry (2013) 1.32
Innervation of cat visual areas 17 and 18 by physiologically identified X- and Y- type thalamic afferents. II. Identification of postsynaptic targets by GABA immunocytochemistry and Golgi impregnation. J Comp Neurol (1985) 1.31
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci (2000) 1.31
Fatty acid amide hydrolase substrate specificity. Bioorg Med Chem Lett (2000) 1.30
Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy. Eur J Neurosci (2000) 1.28
Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr Pharm Des (1998) 1.28
A second mammalian N-myristoyltransferase. J Biol Chem (1998) 1.28
Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem (1996) 1.28
Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience (1992) 1.27
Profiling the specific reactivity of the proteome with non-directed activity-based probes. Chem Biol (2001) 1.26
Exercise activates the endocannabinoid system. Neuroreport (2003) 1.25
Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. Brain (2004) 1.25
Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices. Neuropharmacology (2004) 1.25
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience (2000) 1.25
Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition. Bioorg Med Chem Lett (1999) 1.25
The KCl cotransporter, KCC2, is highly expressed in the vicinity of excitatory synapses in the rat hippocampus. Eur J Neurosci (2001) 1.24
Complete axon arborization of a single CA3 pyramidal cell in the rat hippocampus, and its relationship with postsynaptic parvalbumin-containing interneurons. Eur J Neurosci (1993) 1.22
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol (2000) 1.21
Glutamatergic synapses onto hippocampal interneurons: precision timing without lasting plasticity. Trends Neurosci (1999) 1.21
Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci U S A (2005) 1.21
Large variability in synaptic N-methyl-D-aspartate receptor density on interneurons and a comparison with pyramidal-cell spines in the rat hippocampus. Neuroscience (2003) 1.19
Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. Proc Natl Acad Sci U S A (1998) 1.18
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience (2005) 1.18
Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus. Neuroscience (2001) 1.17
Anandamide transport inhibition by the vanilloid agonist olvanil. Eur J Pharmacol (1999) 1.17
Cerebrodiene: a brain lipid isolated from sleep-deprived cats. Proc Natl Acad Sci U S A (1994) 1.14